(Q44902055)

7 December 2017

title

High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection (English)

1 reference

7 December 2017

0 references

0 references

1 reference

1 reference

hepatocellular carcinoma

1 reference

1 reference

1 reference

Kazuyuki Ohata

1

1 reference

7 December 2017

Keisuke Hamasaki

2

1 reference

7 December 2017

Kan Toriyama

3

1 reference

7 December 2017

Hiroki Ishikawa

4

1 reference

7 December 2017

Kazuhiko Nakao

5

1 reference

7 December 2017

Katsumi Eguchi

6

1 reference

7 December 2017

publication date

1 June 2004

1 reference

Journal of Gastroenterology and Hepatology

7 December 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

7 December 2017

volume

19

1 reference

7 December 2017

issue

6

1 reference

7 December 2017

page(s)

670-675

1 reference

A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Effect of viral status on recurrence after liver resection for patients with hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

A long-term follow-up analysis of serial core promoter and precore sequences in Japanese patients chronically infected by hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Classification of chronic hepatitis: diagnosis, grading and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

High viral loads, serum alanine aminotransferase and gender are predictive factors for the development of hepatocellular carcinoma from viral compensated liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Evidence for an association between the aetiology of cirrhosis and pattern of hepatocellular carcinoma development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Chronic hepatitis B virus infection: treatment strategies for the next millennium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

Nucleolar hypertrophy correlates with hepatocellular carcinoma development in cirrhosis due to HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2004.03360.X

10.1111/J.1440-1746.2004.03360.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference